Echosens™ North America, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases through the use of FibroScan®.
FibroScan®, the non-invasive backbone for cost effectively diagnosing and managing liver disease at point of care, enables physicians to scan patients and view a specific score quantifying their patients liver health without the need of a painful biopsy.
FibroScan® is FDA cleared, supported by over 2,000 peer reviewed publications, and is the reference standard for many of the practice guidelines across a variety of liver diseases.
Company’s Keywords:
noninvasive diagnosis in hepatology, quantitative elastography, evaluation of liver fibrosis, evaluation of liver cirrhosis, liver stiffness measurement, controlled attenuation parameter
<43
<
<2015